PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor

被引：0
|
作者：
Jiang, J. [1 ]
Shi, L. [1 ]
Chen, L. [1 ]
Zhu, Y. [1 ]
Wu, C. [1 ]
Lu, B. [2 ]
机构：
[1] Soochow Univ, Dept Tumor Biol Treatment, Affiliated Hosp 3, Changzhou, Peoples R China
[2] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
183
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [41] Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma
    Lu, Lianghe
    Xing, Kaili
    Wei, Wei
    Ling, Yihong
    Li, Peng
    Li, Shaohua
    Wang, Yan
    Xie, Dan
    Guo, Rongping
    Cai, Muyan
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (04) : 959 - 966
  • [42] Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
    Rajani, Karishma
    Parrish, Christopher
    Kottke, Timothy
    Thompson, Jill
    Zaidi, Shane
    Ilett, Liz
    Shim, Kevin G.
    Diaz, Rosa-Maria
    Pandha, Hardev
    Harrington, Kevin
    Coffey, Matt
    Melcher, Alan
    Vile, Richard
    MOLECULAR THERAPY, 2016, 24 (01) : 166 - 174
  • [43] PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease
    Vega, Maite Duhalde
    Olivera, Daniela
    Davanzo, Gustavo Gastao
    Bertullo, Mauricio
    Noya, Veronica
    de Souza, Gabriela Fabiano
    Muraro, Stefanie Primon
    Castro, Icaro
    Arevalo, Ana Paula
    Crispo, Martina
    Galliussi, German
    Russo, Sofia
    Charbonnier, David
    Rammauro, Florencia
    Jeldres, Mathias
    Alamon, Catalina
    Varela, Valentina
    Batthyany, Carlos
    Bollati-Fogolin, Mariela
    Oppezzo, Pablo
    Pritsch, Otto
    Proenca-Modena, Jose Luiz
    Nakaya, Helder I.
    Trias, Emiliano
    Barbeito, Luis
    Anegon, Ignacio
    Cuturi, Maria Cristina
    Moraes-Vieira, Pedro
    Segovia, Mercedes
    Hill, Marcelo
    SCIENCE ADVANCES, 2022, 8 (38)
  • [44] Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response
    Ji, Wei
    Li, Lanfang
    Zhou, Shiyong
    Qiu, Lihua
    Qian, Zhengzi
    Zhang, Huilai
    Zhao, Peiqi
    JOURNAL OF DRUG TARGETING, 2020, 28 (09) : 982 - 990
  • [45] Talilmogene laherparepvec increases the anti-tumor efficacy of the anti PD-1 immune checkpoint blockade
    Piasecki, Julia
    Le, Tiep
    Ponce, Rafael
    Beers, Courtney
    CANCER RESEARCH, 2015, 75
  • [46] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [47] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [48] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [49] Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
    Lipson, Evan J.
    Lilo, Mohammed T.
    Ogurtsova, Aleksandra
    Esandrio, Jessica
    Xu, Haiying
    Brothers, Patricia
    Schollenberger, Megan
    Sharfman, William H.
    Taube, Janis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [50] Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade
    Wang, Minglei
    Huang, Yiheng
    Chen, Minxin
    Wang, Weiyan
    Wu, Fei
    Zhong, Tao
    Chen, Xiaozheng
    Wang, Fei
    Li, Yang
    Yu, Jinming
    Wu, Meng
    Chen, Dawei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
12345